Introduction
liver enzyme argininosuccinate synthetase (AS), which Citrullinemia is one of four amino acidurias associated catalyzes the conversion of citrulline plus aspartate to with the Krebs-Henseleit urea cycle (Fig. 1) . The disargininosuccinic acid [10] . Although the degree of ease is thought to be due to a deficiency of the normal mental retardation is variable in this disease, the levels of citrulline in serum, urine, and cerebrospinal fluid are usually elevated [4] [5] [6] . Patients with citrullinemia have sporadic episodes of convulsions which are presumed to be associated with ammonia intoxication, despite the fact that the levels of arginine and ornithine as well as the production of urea are often normal.
The particular patient from whom we established this first citrullinemic lymphocyte line was a 33-yearold mentally retarded male, described in detail by Scott-Emuakpor et al. [8] . This patient differed from the patients with citrullinemia described earlier [4, 6] in that he had a reasonably efficient ammonia removal mechanism. Our interest in establishing his lymphocytes in long term culture was, first, to determine whether or not the citrullinemic defect was expressed in cultured lymphoblasts, and, second, to determine whether his cells were genetically homogeneous in their inability to utilize citrulline.
Methods and Materials

Lymphocyte Lines
The continuously propagated lymphocyte lines used in this study were established by the lysate method, described originally by Choi and Bloom [2] . The cell lysate used contains the Epstein-Barr virus which is thought to play a role in the establishment and continuous propagation of the cell lines. To date, no effect o£ the viral genome on the metabolic function of the host cells has been found. Cell line UM-10 was established in April 1970 from a 10-year-old male with the LeschNyhan syndrome. Cell line UM-21 was established in July 1970 from the patient with citrullinemia described above. Cell line UM-43 was derived from a normal 22-year-old male and has been in continuous culture since January 1971. Each line has a modal chromosome number of 46, with an XY chromosome constitution.
Growth Medium
Lymphocytes were maintained in Roswell Park Memorial Institute medium (RPMI) 1640 with 20% fetal calf serum, penicillin, and streptomycin. This medium normally contains 200 mg/liter arginine. For the growth experiments, 0.3 X 10° cells/ml were grown in three types of media: RPMI with 200 mg/liter arginine (Cit~, Arg+); RPMI with 200 mg/liter citrulline substituted for arginine (Cit+, Arg-); and RPMI without citrulline or arginine (Cit-, Arg-). Total cells were counted every 48 hr in a hemacytometer, and viability was determined by trypan blue dye exclusion [11] .
A ntoradiography
Cells from UM-10 and UM-21 (parent and variant) were used in this experiment. We incubated 5 X 10 5 logarithmically growing cells for 48 hr in medium containing 1 juCi/ml ureido-14 C-citrulline (sp act 3.73 mCi/niM [12] ). The cells were washed three times with Hanks' balanced salt solution and centrifuged at 1,000 rpm. They were then resuspended in fetal calf serum, placed on slides, and dipped in Kodak NTB-3 emulsion. After 5 days of exposure, the slides were developed in D-19 for 3 min.
C'-Citrulline Incorporation into Cellular Protein
Cells (5 X 10 r> ) from each line were inoculated into each of three test tubes in 4 ml medium containing no citrulline, arginine, or fetal calf serum and incubated for 12 hr at 37°. This medium was then replaced with an equal volume of medium containing 175 mg/liter cold citrulline and 1 ^Ci/ml ureido-14 Ccitrulline (sp act 3.73 mCi/mM [12] ). The cells were incubated in this medium for an additional 12 hr. The cells were then pipetted into a filter apparatus containing glass fiber filter paper [13] . They were then washed successively with approximately 40 ml each 0.85% saline, 5% cold trichloroacetic acid, and absolute methanol. The filter papers were allowed to air dry and then placed in scintillation vials with 0.5 ml Soluene [14] and incubated at 37° overnight. The counts per minute in the trichloroacetic acid precipitate were determined in a Packard Tri-Carb scintillation counter model 3320 [14] .
Milligrams of protein were determined by a modification of the Lowry method [3] .
Determination of Doubling Times
Cultures for estimation of the population doubling times were initiated with 0.3 X 10 6 cells/ml. The UM-21 cells were placed in Cit~, Arg+ medium. The UM-21 variant (capable of growing in citrulline) was inoculated into Cit+, Arg-medium. The UM-10 cell line was studied in both Cit~, Arg+ and Cit+, Arg-medium. The cell count was determined at 24-hr intervals with a hemacytometer, and the doubling times were calculated by the method of Aoki and Moore [1] .
Assay for Argininosuccinate Synthetase
Lines UM-10, UM-21, and UM-43 were assayed by Dr. P. Snodgrass using a spectrophotometric assay first described by R. T. Schimke [7] . Packed cells (0.4 ml) were tised in the determinations. UM-10 contained 8.77 mg protein/ml, UM-21 contained 15.0 mg protein/ml, and UM-43 contained 8.75 mg of protein/ml.
Results
Growth Curves
The results are presented in Fig. 2 . The UM-10, UM-43, and UM-21 cells grown in RPMI 1640 Cit~, Arg+ showed normal logarithmic growth and reached a maximum live cell density of 1 X 10° cells/ml before being subcultured. The UM-10 and UM-43 cells grown 20 rt'ig. 2. Growth o£ "normal" (UM-10) and citrullinemic (UM-21) lymphocytes in medium which contains no arginine and 20 mg/ 100 ml citrulline (Cit*, Arg") or in medium which contains no cilrulline or arginine (Cif, Arg"). Inoculations o£ 0. ill Arg-, Cit~ medium died within (i clays, whereas UM-21 cells could be maintained for a month in this medium before senescence. The UM-10 and UM-43 cells grown in Cit+, Arg-medium also showed nor-, mal logarithmic growth, whereas UM-21 cells failed to grow in this medium. However, most of the UM-21 cells did remain viable, and the concentration of cells in the original population (0.2 X 10° cells/ml) was maintained for 3-4 weeks. These cells were incubated continuously thereafter in Cit+, Arg-medium, and after a month the cells began to increase in number. Those cells wliich were able to grow in the presence of citrulline constitute a population of cells different from the parental line and are referred to as the UM-21 variant cells. They were maintained in Cit+, Arg-RPMI 1640 medium. Nine clones of the parental UM-21 line are now being studied.
Doubling Times
The UM-10 cells in Cit+, Arg-RPMI 1640 doubled in 24.6 hr, whereas the UM-21 variant cells failed to enter logarithmic growth phase. However, UM-10 and UM-21 in Cit-, Arg+ medium had doubling times of 23.8 and 27.3 hr, respectively. Thus, there was no significant difference between the doubling times of cells from UM-10 that had been growing in medium containing citrulline or in medium containing arginine. The UM-21 cells grown in medium containing arginine had a doubling time similar to that of the UM-10 cells. However, the UM-21 variant cells that had been incubated in medium with citrulline doubled only once in 6 days.
A utoradiography
Cells from UM-10 were labeled heavily and uniformly with 14 C while cells from UM-21 showed no label at all (Fig. 3) . The UM-21 variant cells showed a diverse labeling pattern: 11.7% of cells were labeled heavily (mote than 20 grains/cell), similar to the UM-10 cells; 32.4% of cells were lightly labeled (11-20 grains per cell), i.e., they had incorporated some label but not as much as the UM-10 cells; and 55.9% of cells had incorporated essentially no label (less than 10 grains), as was the case for the UM-21 cells. per 10 r> cells, which is equivalent to 3.3-3.5 X 10~3 mg protein.
The mean counts per minute of the four samples were compared using Duncan's new multiple range test [9] . There is no significant difference (P < 0.01) between the mean counts of UM-10, UM-43, and UM-21 variant, but the means of these three samples do differ significantly (P < 0.01) from the mean counts of UM-21.
Direct Enzyme Assay
No AS was detectable in any of the three lines tested, UM-43, UM-21, and UM-10, which indicates that the level of this enzyme in lymphocyte lines from citrullinemic and noncitrullinemic donors is very low. In the future, a more sensitive radioactive assay for AS will have to be used.
Discussion
Despite the fact that AS was not detectable spectrophotometrically in the lymphocyte lines used in this study, we have considerable indirect evidence here for the expression of this enzyme in lymphocytes established from "normal" donors, and for its lack of expression in UM-21, the citrullinemic cell line. Cells from UM-21 were unable to enter logarithmic growth in medium in which citrulline had been substituted for arginine. These cells also showed a reduced uptake of labeled 14 C-citrulline on autoradiography and a markedly reduced incorporation of labeled citrulline into trichloroacetic acid-precipitable cellular protein.
Our isolation of a metabolic variant of UM-21 may have direct relevance to the clinical situation in this patient. The cells of the variant line showed a heterogeneous labeling pattern but incorporated 14 C-citrulline into cellular protein almost as efficiently as the normal lymphocytes. These findings suggest that some cells from within this citrullinemic patient may have normal or nearly normal citrulline metabolism. Metabolic cooperation between normal and deficient cells might account for the seeming ease with which the patient disposes of ammonia and excretes normal amounts of urea.
Alternatively, and more likely, the variant line could be derived from a back mutation that occurred in vitro during the 2 years that the cells have been in culture. These "normal" or revertant cells might then have been selected for when the UM-21 cells were grown in Cit+, Arg~ medium. The variant line may be comprised of cells with normal activity or of cells with partial activity that survive in selective medium through metabolic cooperation. The fact that the variant line had to be subcultured at a high population density for growth to occur suggests, however, that these cells do not have normal enzyme activity.
The basic defect in citrullinemia is not yet known, although the studies of Tedesco and Mellman [10] on citrullinemic fibroblasts suggest a structural gene mutation. They found that the AS in citrullinemic fibroblasts has an increased K m for its substrate, and concluded that a structurally altered enzyme would be compatible with the reduced ability of the cells to utilize citrulline.
Summary
Peripheral blood lymphocytes were obtained from a patient with citrullinemia and established in continuous culture. These cells were unable to utilize citrulline in the growth medium and failed to incorporate ureido- 14 C-citrulline into cellular protein, which suggests either that they were defective in argininosuccinate synthetase or that they have a primary defect in citrulline transport. Under selective conditions, a variant line arose, which represented either a back mutation or a second in vivo cell population.
Addendum
Assay for argininosuccinate synthetase was recently performed on cell lines UM-43 and UM-21 by Dr. Nancy Kennaway, Department of Pediatrics, University of Oregon Medical School, using a modification of the Schimke method [7] . Dr. Kennaway found the specific activity for the synthetase in UM-43 to be 0.059 mol/mg protein/hr, while the UM-21 parent line had no detectable activity, which confirms the absence of catalytically active synthetase in the cells of this citrullinemic patient.
